LBO — THE MEDICAL CENTER AT FRANKLIN
IRR: 15.8% | MOIC: 2.08x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
15.8%
IRR
2.08x
MOIC
$48.6M
Entry EV
$70.9M
Exit EV
$25.0M
Equity Invested
Sources & Uses
S&UTotal · $48.6M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $18.9M | 38.8% | |
| Sub Debt | $4.7M | 9.7% | |
| Equity | $25.0M | 51.5% | |
| Enterprise Value | $47.2M | 97.1% | |
| Transaction Fees | $1.4M | 2.9% | |
| Total Uses | $48.6M | 100.0% |
Interpretation
INTAt 2.08x MOIC and 15.8% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $6.7M |
| Exit Ev | $70.9M |
| Net Debt At Exit | $18.9M |
| Equity At Exit | $52.0M |
| Equity Invested | $25.0M |
| Total Value Created | $27.0M |
| Value From Growth | $21.3M |
| Value From Multiple | $2.4M |
| Value From Deleveraging | $4.7M |